Concepedia

Publication | Open Access

Treatment with Sunitinib for Patients with Progressive Metastatic Pheochromocytomas and Sympathetic Paragangliomas

DOIFull Paper Access

205

Citations

25

References

2012

Year

Montserrat Ayala‐Ramirez, C. Chougnet, Mouhammed Amir Habra, J. Lynn Palmer, Sophie Leboulleux, Maria E. Cabanillas, Caroline Caramella, Pete Anderson, Abir Al Ghuzlan, Steven G. Waguespack,
The Journal of Clinical Endocrinology & Metabolism

Abstract

Sunitinib is associated with tumor size reduction, decreased [(18)F]FDG-PET/CT uptake, disease stabilization, and hypertension improvement in some patients with progressive metastatic PHEO/PGL. Prospective multi-institutional clinical trials are needed to determine the true benefits of sunitinib.

References

YearCitations

Page 1